Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Tarning

Showing results (31-40 of 248) with videos related to

Pageof 25
Sort By:
The AAPS Journal|March 26, 2022
Population Pharmacodynamic Modeling of Eflornithine-Based Treatments Against Late-Stage Gambiense Human African Trypanosomiasis and Efficacy Predictions of L-eflornithine-Based TherapyCarl Amilon, Mikael Boberg, Joel Tarning, et al.
Plos Neglected Tropical Diseases|March 10, 2022
Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepsideFrauke Assmus, Richard M Hoglund, Frédéric Monnot, et al.
International Health|October 29, 2020
Assessment of the amino acid profile in Thai patients with type 2 diabetes mellitus using liquid chromatography-mass spectrometryNatthida Sriboonvorakul, Wirichada Pan-Ngum, Kittiyod Poovorawan, et al.
Malaria Journal|November 15, 2013
A robust design for identification of the Parasite Clearance EstimatorKris M Jamsen, Stephen B Duffull, Joel Tarning, et al.
Antimicrobial Agents and Chemotherapy|March 1, 2017
Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-PiperaquineJesmin Permala, Joel Tarning, François Nosten, et al.
The AAPS Journal|July 12, 2014
Statistical power calculations for mixed pharmacokinetic study designs using a population approachFrank Kloprogge, Julie A Simpson, Nicholas P J Day, et al.
BMC Research Notes|October 2, 2022
Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malariaJoel Tarning, Lorenz von Seidlein, Arjen M Dondorp, et al.
The Lancet. Infectious Diseases|February 4, 2018
Treatment of uncomplicated and severe malaria during pregnancyUmberto D'Alessandro, Jenny Hill, Joel Tarning, et al.
Current Research in Parasitology & Vector-Borne Diseases|March 27, 2026
Discovery of novel repurposed anthelminthics against <i>Trichinella spiralis</i> and albendazole-resistant nematodes through metabolomics-guided virtual screeningPeerut Chienwichai, Phornpimon Tipthara, Joel Tarning, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Population Pharmacokinetic Modeling of Tribendimidine Metabolites in Opisthorchis viverrini-Infected AdultsFiona Vanobberghen, Melissa A Penny, Urs Duthaler, et al.
Pageof 25

Showing results (31-40 of 248) with videos related to

Sort By:
Pageof 25
The AAPS Journal|March 26, 2022
Population Pharmacodynamic Modeling of Eflornithine-Based Treatments Against Late-Stage Gambiense Human African Trypanosomiasis and Efficacy Predictions of L-eflornithine-Based TherapyCarl Amilon, Mikael Boberg, Joel Tarning, et al.
Plos Neglected Tropical Diseases|March 10, 2022
Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepsideFrauke Assmus, Richard M Hoglund, Frédéric Monnot, et al.
International Health|October 29, 2020
Assessment of the amino acid profile in Thai patients with type 2 diabetes mellitus using liquid chromatography-mass spectrometryNatthida Sriboonvorakul, Wirichada Pan-Ngum, Kittiyod Poovorawan, et al.
Malaria Journal|November 15, 2013
A robust design for identification of the Parasite Clearance EstimatorKris M Jamsen, Stephen B Duffull, Joel Tarning, et al.
Antimicrobial Agents and Chemotherapy|March 1, 2017
Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-PiperaquineJesmin Permala, Joel Tarning, François Nosten, et al.
The AAPS Journal|July 12, 2014
Statistical power calculations for mixed pharmacokinetic study designs using a population approachFrank Kloprogge, Julie A Simpson, Nicholas P J Day, et al.
BMC Research Notes|October 2, 2022
Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malariaJoel Tarning, Lorenz von Seidlein, Arjen M Dondorp, et al.
The Lancet. Infectious Diseases|February 4, 2018
Treatment of uncomplicated and severe malaria during pregnancyUmberto D'Alessandro, Jenny Hill, Joel Tarning, et al.
Current Research in Parasitology & Vector-Borne Diseases|March 27, 2026
Discovery of novel repurposed anthelminthics against <i>Trichinella spiralis</i> and albendazole-resistant nematodes through metabolomics-guided virtual screeningPeerut Chienwichai, Phornpimon Tipthara, Joel Tarning, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Population Pharmacokinetic Modeling of Tribendimidine Metabolites in Opisthorchis viverrini-Infected AdultsFiona Vanobberghen, Melissa A Penny, Urs Duthaler, et al.
Pageof 25